2016
DOI: 10.1016/j.hlc.2016.06.322
|View full text |Cite
|
Sign up to set email alerts
|

Trends in Prescription of Novel Oral Anticoagulants (NOACs) and Warfarin in Australia 2010-2015

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2019
2019
2020
2020

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 0 publications
0
1
0
Order By: Relevance
“…Use of direct oral anticoagulants (DOACs) is constantly increasing. 1 Indications for use include treatment and prophylaxis of deep vein thrombosis or pulmonary embolism and prevention of systemic embolization in non-valvular atrial fibrillation. 2 DOACs provide a stable pharmacokinetic profile and do not require routine drug monitoring, directly addressing shortcomings in managing Warfarin.…”
Section: Introductionmentioning
confidence: 99%
“…Use of direct oral anticoagulants (DOACs) is constantly increasing. 1 Indications for use include treatment and prophylaxis of deep vein thrombosis or pulmonary embolism and prevention of systemic embolization in non-valvular atrial fibrillation. 2 DOACs provide a stable pharmacokinetic profile and do not require routine drug monitoring, directly addressing shortcomings in managing Warfarin.…”
Section: Introductionmentioning
confidence: 99%